These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21083244)

  • 1. Welcome to 'microdosing'.
    Ings RM
    Bioanalysis; 2010 Mar; 2(3):371-2. PubMed ID: 21083244
    [No Abstract]   [Full Text] [Related]  

  • 2. Opinion: Microdosing: safer clinical trials and fewer animal tests.
    Langley G; Farnaud S
    Bioanalysis; 2010 Mar; 2(3):393-5. PubMed ID: 21083249
    [No Abstract]   [Full Text] [Related]  

  • 3. Microdosing in early lead discovery.
    Jekunen AP; Pauwels EK; Kairemo KJ
    Bioanalysis; 2010 Mar; 2(3):421-8. PubMed ID: 21083252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in microdosing and other exploratory human pharmacokinetic studies for early drug development.
    Oosterhuis B
    Bioanalysis; 2010 Mar; 2(3):377-9. PubMed ID: 21083246
    [No Abstract]   [Full Text] [Related]  

  • 5. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To make better therapeutics, companies strive to increase the content of results and get them faster.
    Szpir M
    Biotechniques; 2007 Apr; 42(4 Suppl):S3-5. PubMed ID: 18798735
    [No Abstract]   [Full Text] [Related]  

  • 7. Traditional drug-discovery model ripe for reform.
    Cressey D
    Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796
    [No Abstract]   [Full Text] [Related]  

  • 8. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
    Perakslis ED; Van Dam J; Szalma S
    Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-diagnostic co-development: how to harness the value.
    Blair ED; Blakemore JA
    Drug Discov Today; 2011 Oct; 16(19-20):902-5. PubMed ID: 21888987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in risks associated with new drug development: success rates for investigational drugs.
    DiMasi JA; Feldman L; Seckler A; Wilson A
    Clin Pharmacol Ther; 2010 Mar; 87(3):272-7. PubMed ID: 20130567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative business models for drug discovery.
    Bunin BA; Ekins S
    Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585
    [No Abstract]   [Full Text] [Related]  

  • 12. Q&A: Bernard Munos.
    Bender E
    Nature; 2016 May; 533(7602):S59. PubMed ID: 27167392
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynavax and Coley Pharmaceutical Group initiate rituximab combination trials.
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):138. PubMed ID: 12113231
    [No Abstract]   [Full Text] [Related]  

  • 14. The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.
    Woosley RL; Myers RT; Goodsaid F
    Clin Pharmacol Ther; 2010 May; 87(5):530-3. PubMed ID: 20407457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug development: from concept to marketing!
    Tamimi NA; Ellis P
    Nephron Clin Pract; 2009; 113(3):c125-31. PubMed ID: 19729922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropical disease: A neglected cause.
    Laursen L
    Nature; 2016 May; 533(7602):S68-9. PubMed ID: 27167396
    [No Abstract]   [Full Text] [Related]  

  • 17. Human microdosing for the prediction of patient response.
    Henderson PT; Pan CX
    Bioanalysis; 2010 Mar; 2(3):373-6. PubMed ID: 21083245
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I studies in Spain: involvement of the multinational industry.
    Alcaide A
    Methods Find Exp Clin Pharmacol; 1999; 21 Suppl B():37. PubMed ID: 10599046
    [No Abstract]   [Full Text] [Related]  

  • 19. Translational regenerative medicine research: essential to discovery and outcome.
    Mason C; Dunnill P
    Regen Med; 2007 May; 2(3):227-9. PubMed ID: 17511558
    [No Abstract]   [Full Text] [Related]  

  • 20. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.